StockData
Apollomics Inc. logo

Apollomics Inc. (APLM) stock

APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 0/30
$16.45−0.39 (-2.32%)

Close on Nov 18, 2026Market cap $36.13MP/E –Yield –

Apollomics r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $5.53M, down 77.5% from the year before. The highest annual figure on record is $35.57M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.53M-77.5%
FY2024Dec 31, 2024$24.57M-28.2%
FY2023Dec 31, 2023$34.19M-3.6%
FY2022Dec 31, 2022$35.46M-0.3%
FY2021Dec 31, 2021$35.57M+13.1%
FY2020Dec 31, 2020$31.44M–

More Apollomics figures

See a number that looks wrong?